Related Experiment Video
Updated: Sep 15, 2025

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
Published on: June 23, 2018
Hepcidin promotes oral ulcer healing via amphiregulin production in rats
Naoto Taguchi1,2, Suzuro Hitomi2, Hitoshi Sato1
1Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, Tokyo, Japan.
Background/Purpose:
Hepcidin is an antimicrobial peptide that regulates iron metabolism. Recently, hepcidin was reported to promote wound healing. However, the mechanism underlying hepcidin signaling in the oral mucosa remains unclear. In the present study, we examined the mechanism by which hepcidin accelerates healing in a rat model of oral ulcerative mucositis.
Materials And Methods:
In male Wistar rats, 50 % acetic acid was applied to the labial fornix region of the inferior incisors to create a model of oral ulcerative mucositis. The ulcerative mucositis severity was evaluated using an oral mucositis score. Hepcidin expression, phosphorylation of the hepcidin receptor ferroportin and the levels of the epidermal growth factor amphiregulin were assessed using immunohistochemistry and western blotting. Hepcidin was applied to the oral mucosal region of rats with exacerbated oral ulcerative mucositis, which developed following acetic acid treatment after extraction of the submandibular and sublingual glands.
Results:
Two and five days after acetic acid treatment, hepcidin levels increased in the ulcerated region and saliva. Ferroportin in the ulcerated region was phosphorylated 2 days after acetic acid treatment. The expression and amount of amphiregulin in the ulcerated region increased on days 2 and 5. In exacerbated oral ulcerative mucositis rats, the oral ulcerative mucositis healing period was prolonged, and hepcidin and amphiregulin levels in the ulcerated region decreased. Daily hepcidin application to the ulcerated region shortened the healing period in exacerbated oral ulcerative mucositis rats.
Conclusion:
Oral ulcerative mucositis-induced increase in hepcidin promotes healing through the amphiregulin production of via ferroportin activation.
More Related Videos
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
03:57Author Spotlight: Exploring Corneal Innate Immunity and Delayed Wound Healing in Diabetic Patients
Published on: January 10, 2025
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...